This biotech could rack up 10X gains 🚀

See why it could be the top micro-cap play to add to your radar in June.                                                                                                                                                                                                                                                                                                                                                                                                                 June 17, 2024 | [Read Online]( [Elite Trade Club] [Catalysts are Piling up for this Fast-Growing Biotech Company]( As regenerative medicine continues to find its way into the mainstream, emerging biotech company[Â]( is making waves for its cutting-edge therapeutics. The company has been capturing Wall Street’s attention as its share price has risen from around $1 in July of 2023 to as high as $7.00 by year-end. [This year share prices have exceeded $9!]( Better yet, Zacks Small-Cap Research just lifted its price target, and the company’s preliminary numbers show net revenues for 4Q2023 jumped by [more than 1300% increase from the year ago period!]( Zack’s Small Cap Research believes that BioStem has a solid foothold in that tough to break into community, and the option of its promising pipeline of products could continue to accelerate. [Discover why there could be further upside ahead for BioStem Technologies in 2024!]([(Ticker Inside)]( This is a PAID ADVERTISEMENT provided to subscribers of [EliteTrade.Club](. Although we have sent you this email, EliteTrade.club does NOT specifically endorse this product nor is it responsible for the content of this advertisement. Furthermore, we make no guarantee or warranty about what is advertised above. Update your email preferences or unsubscribe [here]( © 2024 Elite Trade Media LLC 1969 Alafaya Tr., Suite #247 Orlando, Florida 32828, United States of America [[beehiiv logo]Powered by beehiiv](